ERBB2 and breast carcinoma: Our analysis, primarily based on bulk RNA-seq of overall cohorts, did not allow for a detailed investigation of how the ARPS performs or how the five genes function within distinct molecular subtypes of breast cancer (e.g., Luminal, HER2+, Triple-Negative), which have vastly different biologies and treatment responses.